SMO ClinPlus CO.,LTD.

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40016101

Informations générales

Localisation

China

Asia

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

02/10/2025

Objectifs à court terme (Near-Term)

Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%

2015 (année de référence)2030

Description complète des objectifs

Near-Term Targets: SMO ClinPlus CO.,LTD. commits to reduce absolute scope 1 and 2 GHG emissions 42.0% by 2030 from a 2024 base year. SMO ClinPlus CO.,LTD. also commits to reduce absolute scope 3 GHG emissions from fuel- and energy-related activities, business travel and employee commuting 25.0% within the same timeframe.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Source : Science Based Targets initiative | Données publiques